Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine before embryo transfer in ICSI cycles
IRCT20101227005485N11Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amlodipine in Recurrent Implantation Failure (RIF) and female infertility (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Pulsatility Index, Resistance Index and 2 more. Started Jan 2023; status: completed.
02
Drugs
amlodipine
03
Conditions
Recurrent Implantation Failure (RIF)female infertility
Beyond the preview
Go deeper on IRCT20101227005485N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101227005485N11.